Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

β-catenin helps hair follicle stem cells grow by activating a specific cell pathway.

Blocking the androgen receptor in skin cells reduces their growth response to male hormones, suggesting a possible treatment for skin conditions linked to androgens.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

DPP may help hair regrowth by improving blood vessel function under stress.

Nonpalmoplantar skin cells can be made to express keratin 9 by interacting with palmoplantar fibroblasts.

Progesterone protects brain cells, but Provera does not.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Higher levels of miR-1199-5p may reduce the effectiveness of certain prostate treatments.

Parsley contains compounds that might be good for treating hair loss.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Certain interactions help prepare the androgen receptor for pairing and activation, which is important for its role in development and disease.

A specific mutation in PA-PLA1α causes abnormal hair growth.

EP 2 receptor is essential for heart repair by helping macrophages work properly.

DPP4-positive fibroblasts play a major role in producing proteins that lead to skin fibrosis.

The LEF-1 binding site enhances gene expression in hair follicles, with other proteins aiding specific regulation.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

TPA is about 50 times more effective at promoting tumors than MZ.

MARCKSL1 is important for wound healing and could be a target to reduce scarring.

Wedelolactone selectively kills prostate cancer cells without harming normal cells.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Oral JAK inhibitors show promise for treating alopecia areata but have challenges like relapse and side effects.

Androgen signaling reduces Wnt activity, affecting prostate stem cell growth.

JAK inhibitors may help treat alopecia areata in children, but their safety needs careful evaluation.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.

Sfrp2 increases during hair follicle catagen phase and slows keratinocyte growth.

p120-catenin helps control skin inflammation by regulating cadherin levels.